Discovery and Basic Research
Category: Late Breaking Poster Abstract
												Saad S. Niaz, M.S. (he/him/his)
PhD Researcher
King's College London
SLOUGH, England, United Kingdom
Bahijja Raimi-Abraham, Ph.D. (she/her/hers)
King's College London
London, England, United Kingdom
Bahijja Raimi-Abraham, Ph.D. (she/her/hers)
King's College London
London, England, United Kingdom
Ben Forbes, Ph.D.
King's College London
London, England, United Kingdom
James Hart, B.S.
BASF SE Pharma Solutions
Stockport, England, United Kingdom
												Lindsay M. Johnson, Ph.D.
Global Technical Marketing Manager
BASF Corporation
New York, New York, United States
Fig. 1. Theoretical Polymer-Polymer Miscibility. (a) Solubility parameters (δ) of PLA, PVA, SP, KV64 and PVP. Solubility parameters, with units MPa1/2, were determined using the Hoftyzer-Van Krevelen method and Hoy method.  (b) Theoretical Miscible Polymer Combinations. Miscibility was determined using the Hoftyzer-Van Krevelen method and Hoy method.
Fig. 2. Experimental Polymer-Polymer Miscibility. (a)  DSC thermogram of Polylactic acid (PLA) and Soluplus (SP) combinations. This figure shows the DSC thermogram of PLA and SP in 50/50 (%w/w), 70/30 (%w/w), and 100/0 (%w/w) ratios upon cooling. DSC was performed at 10°C/min in an aluminium open pan system. (b) ATR-FTIR spectra of Polylactic acid (PLA) and Soluplus (SP) combinations. This figure shows the ATR-FTIR spectra of PLA and SP in 50/50 (%w/w), 70/30 (%w/w), and 100/0 (%w/w) ratios and shows the % transmittance (%T) against the wavelength (cm-1). ATR-FTIR was performed on the melted systems obtained from DSC.
Fig. 3. In Vitro Caco-2 Cell Viability and IC50. (a) Caco-2 Cell Viability of Polymer Combinations at 5mg/mL.  Viability of 50/50 (%w/w) polymer combinations. (b) Caco-2 Cell Viability of Polymer Combinations at 5mg/mL.  Viability of 70/30 (%w/w) polymer combinations. (c) IC50 Values of Top Five Polymer Combinations. IC50 was determined via nonlinear regression. All data are represented as the mean ± SD (n = 3). * p ≤ 0.05 comparing with a 0mg/mL control.